乳酸酸通过CBX3调节的基因素乳化重新编程质母细胞瘤免疫力
Shuai Wang1,2, Tengfei Huang1, Qiulian Wu1
1Hillman Cancer Center and Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
The Journal of clinical investigation
|November 15, 2024
概括
脑瘤细胞产生的乳酸重新编程了它们的表观遗传学,通过CD47的"不要吃我"信号增加了免疫逃避. 向乳酸或CBX3可以提高抗癌免疫力和治疗效率.
科学领域:
- 神经瘤学神经瘤学
- 癌症免疫学 癌症免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 质母细胞瘤 (GBM) 是一种侵袭性脑癌.
- GBM干细胞 (GSCs) 驱动瘤生长和免疫逃避.
- 瘤将新陈代谢重新编程为糖解,产生乳酸盐.
研究的目的:
- 调查乳酸在GBM免疫逃避中的作用.
- 确定乳酸诱导的表观遗传重编程的机制.
- 探索针对乳酸代谢的治疗策略.
主要方法:
- 使用患者衍生的GSC和微质/巨细胞.
- 分析了基斯乳酸和CD47的表达.
- 研究了CBX3和EP300的相互作用.
- 评估了乳酸生产和CBX3的药理向.
主要成果:
- 乳酸盐诱导GBM细胞中的基因组乳酸化,促进免疫抑制.
- 乳酸上调CD47,一个"不要吃我"信号,在GBM细胞.
- CBX3与EP300结合,改变其基质特异性并驱动免疫抑制转录.
- 向乳酸生产或CBX3可以提高抗GBM疗法的疗效.
结论:
- 乳酸中介于GBM中代谢诱导的表观遗传重编程.
- 这种重新编程有助于CD47依赖的免疫逃避.
- 向乳酸代谢或CBX3可以增强免疫瘤疗法.
相关概念视频
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...